March 15 (Reuters) - Elixinol Global Ltd EXL.AX :
* ELIXINOL TO ACQUIRE 100% OF CANNACARE HEALTH
* DEAL FOR UPFRONT CONSIDERATION OF EUR 9.0 MILLION
* UPON ATTAINMENT OF FY2021 REVENUE OF EUR 12.9 MILLION & 20% EBITDA, MAXIMUM EARN-OUT OF EUR 15.0 MILLION PAYABLE IN CO'S SHARES
* DEAL EXPECTED TO LEAD TO SIGNIFICANT IMPROVEMENT IN CO'S EBITDA POSITION & ACCELERATE PATHWAY TO PROFITABILITY IN NEAR-TERM